State Street’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.26M Buy
1,346,659
+54,588
+4% +$454K ﹤0.01% 2714
2025
Q4
$10.7M Buy
1,292,071
+358,231
+38% +$3.86M ﹤0.01% 2615
2025
Q3
$13.6M Buy
933,840
+192,788
+26% +$2.31M ﹤0.01% 2449
2025
Q2
$8.34M Buy
741,052
+405,682
+121% +$3.14M ﹤0.01% 2694
2025
Q1
$1.91M Buy
335,370
+96,541
+40% +$984K ﹤0.01% 3262
2024
Q4
$2.35M Buy
238,829
+22,808
+11% +$195K ﹤0.01% 3266
2024
Q3
$1.76M Sell
216,021
-36,296
-14% -$364K ﹤0.01% 3363
2024
Q2
$3.37M Sell
252,317
-412,320
-62% -$12.3M ﹤0.01% 3091
2024
Q1
$30.8M Buy
664,637
+13,296
+2% +$688K ﹤0.01% 1973
2023
Q4
$44M Buy
651,341
+89,998
+16% +$5.51M ﹤0.01% 1774
2023
Q3
$40.6M Buy
561,343
+44,249
+9% +$3.54M ﹤0.01% 1748
2023
Q2
$38.5M Buy
517,094
+149,406
+41% +$8.84M ﹤0.01% 1827
2023
Q1
$19.6M Buy
367,688
+20,025
+6% +$1.27M ﹤0.01% 2248
2022
Q4
$23.5M Buy
347,663
+17,896
+5% +$1.65M ﹤0.01% 2124
2022
Q3
$41.2M Buy
329,767
+19,471
+6% +$2.32M ﹤0.01% 1732
2022
Q2
$29.5M Buy
310,296
+210,294
+210% +$25.6M ﹤0.01% 1970
2022
Q1
$16.1M Buy
100,002
+5,060
+5% +$985K ﹤0.01% 2545
2021
Q4
$31.6M Buy
+94,942
New +$45.1M ﹤0.01% 2137

Other funds holding DNA

State Street's DNA Position: Q1 2026 in Review

State Street increased its Ginkgo Bioworks (DNA) stake by 4.2% in Q1 2026, buying an estimated $454K and bringing the position to 1,346,659 shares worth $8.26M. The position accounts for ﹤0.01% of the portfolio, ranked #2714.

State Street first reported a position in DNA in Q4 2021 and has held it in 18 quarters since. The position peaked at $44M in Q4 2023. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • State Street held 1,346,659 shares of Ginkgo Bioworks worth $8.26M as of Q1 2026.
  • State Street bought 54,588 Ginkgo Bioworks shares in Q1 2026, an estimated $454K.
  • Ginkgo Bioworks made up ﹤0.01% of State Street's portfolio in Q1 2026, its #2714 holding.
  • State Street first reported a position in Ginkgo Bioworks in Q4 2021 and has held it in 18 quarters since.
  • State Street's Ginkgo Bioworks position peaked at $44M in Q4 2023.
  • 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.